loadpatents
Patent applications and USPTO patent grants for Romeuf; Christophe de.The latest application filed is for "anti-cd303 monoclonal antibodies".
Patent | Date |
---|---|
Chimeric protein in the treatment of amyloidosis Grant 11,345,730 - Romeuf , et al. May 31, 2 | 2022-05-31 |
Anti-CD303 monoclonal antibodies Grant 10,611,843 - Fournier , et al. | 2020-04-07 |
Anti-cd303 Monoclonal Antibodies App 20180086834 - FOURNIER; Nathalie ;   et al. | 2018-03-29 |
Monoclonal antibodies with enhanced ADCC function Grant 9,718,889 - Beliard , et al. August 1, 2 | 2017-08-01 |
Chimeric Protein In The Treatment Of Amyloidosis App 20160264637 - ROMEUF; Christophe DE ;   et al. | 2016-09-15 |
Use of ADCC-optimized antibodies for treating weak patients Grant 9,109,020 - Bourel , et al. August 18, 2 | 2015-08-18 |
Monoclonal Antibodies With Enhanced Adcc Function App 20150152189 - Beliard; Roland ;   et al. | 2015-06-04 |
Use Of Adcc-optimized Antibodies For Treating Weak Patients App 20140017243 - Bourel; Dominique ;   et al. | 2014-01-16 |
Use of ADCC-optimized antibodies for treating low-responder patients Grant 7,713,524 - Bourel , et al. May 11, 2 | 2010-05-11 |
Method of measuring activation of effector cells Grant 7,595,165 - Romeuf , et al. September 29, 2 | 2009-09-29 |
Anti-rhesus D monoclonal antibodies Grant 7,541,029 - Beliard , et al. June 2, 2 | 2009-06-02 |
Novel lgG3 Antibodies for Stimulating Phagocytosis App 20070218052 - Romeuf; Christophe De ;   et al. | 2007-09-20 |
Anti-Rhesus D monoclonal antibodies App 20070009522 - Beliard; Roland ;   et al. | 2007-01-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.